AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

XPeng Inc.

$10.71 -$9.72 (-47.58%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$10.54
Day Range
$10.61$10.81
Year Range
$10.31$28.23
Market Cap
10.17B
AVG Volume
7.36M
Trailing/Forward PE
-21.45/-
PEG ratio
0.22
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
New York Stock ExchangeUS
Revenue (CNY)
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Revenue (CNY) by quarter
PeriodRevenue (CNY)
26 Q219.69B
26 Q112.95B
25 Q421.95B
25 Q320.38B
25 Q218.27B
25 Q115.81B
24 Q416.11B
24 Q310.1B
24 Q28.11B
24 Q16.55B
Net Income (CNY)
-2B-1B01B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Net Income (CNY) by quarter
PeriodNet Income (CNY)
26 Q2-1.33B
26 Q1-1.77B
25 Q4377.92M
25 Q3-380.87M
25 Q2-477.75M
25 Q1-664.05M
24 Q4-1.33B
24 Q3-1.81B
24 Q2-1.28B
24 Q1-1.37B
Operating Income (CNY)
-3B-2B-1B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Operating Income (CNY) by quarter
PeriodOperating Income (CNY)
26 Q2-1.32B
26 Q1-2.1B
25 Q4-911.93M
25 Q3-751.05M
25 Q2-934.65M
25 Q1-1.04B
24 Q4-1.56B
24 Q3-1.85B
24 Q2-1.61B
24 Q1-1.65B
EBITDA (CNY)
-2B-1B01B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV EBITDA (CNY) by quarter
PeriodEBITDA (CNY)
26 Q2-1.32B
26 Q1-1.6B
25 Q4475.17M
25 Q3-294.35M
25 Q2-455.89M
25 Q1-519.84M
24 Q4-1.26B
24 Q3-1.69B
24 Q2-1.26B
24 Q1-1.28B
Cash Flows (CNY)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Cash Flows (CNY) by quarter
PeriodCash Flows (CNY)
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
EPS (CNY)
-4-20224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV EPS (CNY) by quarter
PeriodEPS (CNY)
26 Q2-2.86
26 Q1-3.72
25 Q40.78
25 Q3-0.4
25 Q2-0.5
25 Q1-0.7
24 Q4-1.41
24 Q3-1.9
24 Q2-1.36
24 Q1-1.44
Expenses (CNY)
02B4B6BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Expenses (CNY) by quarter
PeriodExpenses (CNY)
26 Q25.4B
26 Q14.76B
25 Q45.59B
25 Q34.92B
25 Q24.37B
25 Q13.93B
24 Q44.28B
24 Q33.27B
24 Q23.04B
24 Q12.74B
Cash & Debt (CNY)
010B20B30B40BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Cash & Debt (CNY) by quarter
PeriodCash & Debt (CNY)
26 Q231.7B
26 Q137.12B
25 Q434.96B
25 Q334.7B
25 Q233.87B
25 Q132.51B
24 Q432.72B
24 Q327.07B
24 Q228.14B
24 Q133.62B
Debt ratios
-100102024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Debt ratios by quarter
PeriodDebt ratios
26 Q2-3.34
26 Q1-2.26
25 Q419.38
25 Q3-0
25 Q20.81
25 Q13.13
24 Q43.06
24 Q32.12
24 Q21.68
24 Q12.13
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Margins by quarter
PeriodMargins
26 Q220.68%
26 Q120.58%
25 Q421.31%
25 Q320.14%
25 Q217.33%
25 Q115.56%
24 Q414.44%
24 Q315.26%
24 Q214%
24 Q112.89%
Return on Capital
-8%-6%-4%-2%0%2%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Return on Capital by quarter
PeriodReturn on Capital
26 Q2-4.93%
26 Q1-6.25%
25 Q41.24%
25 Q3-1.27%
25 Q2-1.57%
25 Q1-2.16%
24 Q4-4.25%
24 Q3-5.64%
24 Q2-3.78%
24 Q1-3.89%
Shares Outstanding
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2478.18M
26 Q1477.64M
25 Q4477.16M
25 Q3952.69M
25 Q2945.68M
25 Q1945.68M
24 Q4945.68M
24 Q3944.01M
24 Q2944.03M
24 Q1942.7M
Book Value Per Share (CNY)
02040608024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Book Value Per Share (CNY) by quarter
PeriodBook Value Per Share (CNY)
26 Q256.5
26 Q159.36
25 Q463.64
25 Q331.48
25 Q232.08
25 Q132.47
24 Q433.07
24 Q333.93
24 Q236.02
24 Q137.26
Total Assets (CNY)
050B100B150B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XPEV Total Assets (CNY) by quarter
PeriodTotal Assets (CNY)
26 Q2101.62B
26 Q1100.44B
25 Q4103.16B
25 Q398.31B
25 Q292.43B
25 Q188.89B
24 Q482.71B
24 Q376.43B
24 Q275B
24 Q179.9B
Employee Count
05K10K15K20K202020212022202320242025
XPEV Employee Count by quarter
PeriodEmployee Count
202519.88K
202415.36K
202313.55K
202215.83K
202113.98K
20205.08K
Free Cash Flow Yield
0%0.05%0.1%0.15%0.2%med 0%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XPEV Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 260%
Sep 260%
Sep 260%
Aug 260%
Aug 260%
Aug 260%
Aug 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jun 260%
Jun 260%
Jun 260%
Jun 260%
May 260%
May 260%
May 260%
May 260%
May 260%
Apr 260%
Apr 260%
Apr 260%
Apr 260%
Mar 260%
Mar 260%
Mar 260%
Mar 260%
Feb 260%
Feb 260%
Feb 260%
Feb 260%
Jan 260%
Jan 260%
Jan 260%
Jan 260%
Jan 260%
Dec 250%
Dec 250%
Dec 250%
Dec 250%
Nov 250%
Nov 250%
Nov 250%
Nov 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Sep 250%
Sep 250%
Sep 250%
Sep 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Jul 250%
Jul 250%
Jul 250%
Jul 250%
Jun 250%
Jun 250%
Jun 250%
Jun 250%
May 250%
May 250%
May 250%
May 250%
May 250%
Apr 250%
Apr 250%
Apr 250%
Apr 250%
Mar 250%
Mar 250%
Mar 250%
Mar 250%
Feb 250%
Feb 250%
Feb 250%
Feb 250%
Jan 250%
Jan 250%
Jan 250%
Jan 250%
Jan 250%
Dec 240%
Dec 240%
Dec 240%
Dec 240%
Nov 240%
Nov 240.15%
Nov 240.14%
Nov 240.13%
Nov 240.16%
Oct 240.17%
Price to Sales
012345med 2.24Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XPEV Price to Sales by quarter
PeriodPrice to Sales
Sep 260.46
Sep 260.45
Sep 260.47
Aug 260.49
Aug 260.53
Aug 260.51
Aug 260.53
Jul 260.57
Jul 260.54
Jul 260.6
Jul 260.57
Jul 260.58
Jun 260.53
Jun 260.58
Jun 260.64
Jun 260.7
May 260.72
May 260.66
May 260.66
May 260.66
May 260.67
Apr 260.71
Apr 260.77
Apr 260.74
Apr 260.76
Mar 260.73
Mar 260.75
Mar 261.86
Mar 261.61
Feb 261.63
Feb 261.64
Feb 261.67
Feb 261.66
Jan 261.69
Jan 261.81
Jan 261.94
Jan 261.89
Jan 261.93
Dec 251.97
Dec 251.89
Dec 251.81
Dec 251.91
Nov 252.08
Nov 251.95
Nov 252.78
Nov 252.5
Oct 252.62
Oct 252.41
Oct 252.37
Oct 252.35
Oct 252.58
Sep 252.55
Sep 252.42
Sep 252.33
Sep 252.22
Aug 252.35
Aug 252.67
Aug 252.67
Aug 252.74
Aug 252.46
Jul 252.56
Jul 252.48
Jul 252.35
Jul 252.55
Jun 252.45
Jun 252.47
Jun 252.46
Jun 252.64
May 252.62
May 252.71
May 253.45
May 253.29
May 253.32
Apr 253.39
Apr 253.08
Apr 253.64
Apr 253.53
Mar 253.57
Mar 253.95
Mar 254.29
Mar 254.26
Feb 253.91
Feb 253.33
Feb 253.02
Feb 253.08
Jan 252.75
Jan 252.65
Jan 252.58
Jan 252.24
Jan 252.14
Dec 242.3
Dec 242.3
Dec 242.23
Dec 242.27
Nov 242.18
Nov 242.25
Nov 242.4
Nov 242.71
Nov 242.14
Oct 242.06
Price/Operating Cashflow
0200400600800med 132.6Mar 23Jun 23Sep 23Jan 24Apr 24Aug 24Nov 24
XPEV Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Nov 24655.38
Nov 24699.64
Nov 24789.98
Nov 24623.06
Oct 24601.84
Oct 24565.77
Oct 24692.33
Oct 24682.73
Sep 24677.3
Sep 24514.05
Sep 24483.21
Sep 24459.7
Aug 24433.47
Aug 24122.76
Aug 24122.21
Aug 24120.83
Aug 24133.05
Jul 24151.66
Jul 24150.99
Jul 24157.54
Jul 24141.5
Jun 24130.93
Jun 24137.97
Jun 24128.23
Jun 24145.19
May 24147.91
May 24144.65
May 24146.03
May 24136.05
May 24159.77
Apr 24138.38
Apr 24122.21
Apr 2487.73
Apr 2486.86
Mar 2490.18
Mar 24100.09
Mar 24112.71
Mar 24111.16
Mar 24116.35
Feb 24100.9
Feb 24111.27
Feb 2499.23
Feb 2495.71
Jan 24104.6
Jan 24112.68
Jan 24137.06
Jan 24151.86
Dec 23168.27
Dec 23160.03
Dec 23167.36
Dec 23176.38
Dec 23182.58
Nov 23203.01
Nov 23186.05
Nov 23170.92
Nov 23192.28
Oct 23165.28
Oct 23150.86
Oct 23181.17
Oct 23203.74
Sep 23205.98
Sep 23184.37
Sep 23204.56
Sep 23195.77
Sep 23208.75
Aug 23154.85
Aug 23132.16
Aug 23142.77
Aug 23159.2
Jul 23202.64
Jul 23126.8
Jul 23121.32
Jul 23123.91
Jun 23117.93
Jun 2386.12
Jun 2398.26
Jun 2376.62
Jun 2372.44
May 2370.09
May 2376.48
May 2382.69
May 2386.97
Apr 2379.46
Apr 2377.15
Apr 2382.46
Apr 2385.37
Mar 2392.34
Mar 2379.95
Mar 2373.66
Mar 2368.33
Mar 2380.39
Feb 2389.35
Feb 23100.07
Feb 2396.71
Feb 23108.76
Jan 23110.88
Jan 2397.5
Jan 23102.38
Jan 23105.71
Dec 22104.85
Price to Book
0246med 3.93Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XPEV Price to Book by quarter
PeriodPrice to Book
Sep 261.27
Sep 261.25
Sep 261.3
Aug 261.37
Aug 261.38
Aug 261.33
Aug 261.38
Jul 261.48
Jul 261.41
Jul 261.54
Jul 261.49
Jul 261.5
Jun 261.38
Jun 261.51
Jun 261.65
Jun 261.82
May 261.87
May 261.66
May 261.67
May 261.67
May 261.7
Apr 261.79
Apr 261.94
Apr 261.87
Apr 261.91
Mar 261.84
Mar 261.9
Mar 264.37
Mar 263.79
Feb 263.83
Feb 263.87
Feb 263.94
Feb 263.91
Jan 263.97
Jan 264.26
Jan 264.57
Jan 264.44
Jan 264.54
Dec 254.62
Dec 254.44
Dec 254.26
Dec 254.49
Nov 254.91
Nov 254.6
Nov 255.53
Nov 254.98
Oct 255.21
Oct 254.8
Oct 254.71
Oct 254.67
Oct 255.12
Sep 255.07
Sep 254.8
Sep 254.63
Sep 254.41
Aug 254.67
Aug 255.3
Aug 254.36
Aug 254.47
Aug 254.01
Jul 254.19
Jul 254.05
Jul 253.84
Jul 254.16
Jun 254
Jun 254.04
Jun 254.02
Jun 254.32
May 254.28
May 254.42
May 254.51
May 254.29
May 254.34
Apr 254.42
Apr 254.02
Apr 254.3
Apr 254.17
Mar 254.22
Mar 254.66
Mar 255.06
Mar 255.03
Feb 254.61
Feb 253.93
Feb 253.56
Feb 253.64
Jan 253.25
Jan 253.13
Jan 253.05
Jan 252.64
Jan 252.53
Dec 242.72
Dec 242.72
Dec 242.64
Dec 242.68
Nov 242.57
Nov 242.4
Nov 242.56
Nov 242.89
Nov 242.28
Oct 242.2
XPeng Inc.
XPEV
Stockpicker

Video analysis: XPEV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XPEV

China's Auto Slump Masks Record NEV Penetration & Robust Exports

zacks.com · 10 Sep 2026

China's Auto Slump Masks Record NEV Penetration & Robust Exports

China's auto market is weakening at home even as record NEV adoption and surging exports point to a powerful shift in the industry.

AI & Robotics in 2026: 16 Recent Developments for Investors

etftrends.com · 9 Sep 2026

AI & Robotics in 2026: 16 Recent Developments for Investors

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper inference, AI systems reaching into laboratories and physical equipment, robots learning from fewer demonstrations, and new capital and infrastructure forming around commercial deployment.

China's EV makers shift gears to focus on humanoids as car market slows

cnbc.com · 9 Sep 2026

China's EV makers shift gears to focus on humanoids as car market slows

Xpeng, Xiaomi and other Chinese electric car companies are directly or indirectly expanding into humanoid robotics. It's part of a bid to reshape "capital valuation narratives," said Kevin Li, associate director at Counterpoint Research.

Tesla, XPENG Push Humanoid Robots Toward Mass Production

benzinga.com · 8 Sep 2026

Tesla, XPENG Push Humanoid Robots Toward Mass Production

For years, the humanoid robotics race has been about proving the technology works. This week, the conversation shifted to something arguably more important: whether companies can manufacture these machines at scale.

Wall Street Bulls Look Optimistic About XPeng (XPEV): Should You Buy?

zacks.com · 8 Sep 2026

Wall Street Bulls Look Optimistic About XPeng (XPEV): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Nykredit A S Invests $825,000 in XPENG Inc. Sponsored ADR $XPEV

defenseworld.net · 8 Sep 2026

Nykredit A S Invests $825,000 in XPENG Inc. Sponsored ADR $XPEV

Nykredit A S purchased a new position in shares of XPENG Inc. Sponsored ADR (NYSE: XPEV) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 62,289 shares of the company's stock, valued at approximately $825,000. Several other hedge funds have also recently added

IRON, the World's First Advanced General-Purpose Humanoid Robot, Walks off the Production Lines as XPENG's Humanoid Robot Manufacturing Facility Is Officially Commissioned

prnewswire.com · 7 Sep 2026

IRON, the World's First Advanced General-Purpose Humanoid Robot, Walks off the Production Lines as XPENG's Humanoid Robot Manufacturing Facility Is Officially Commissioned

XPENG has officially commissioned its humanoid robot production lines and completed the production-lines manufacturing of the world's first advanced humanoid robot, which autonomously walked off the lines, marking a critical leap from R&D prototyping to production-lines manufacturing. XPENG's humanoid robot production lines feature core process automation exceeding 80%, setting a new manufacturing benchmark with a precision, flexible, and intelligent production line.

Nio Falls 4% as Memory Chip Costs and Revenue Miss Overshadow Doubled Vehicle Margin, XPeng Holds Steady

247wallst.com · 1 Sep 2026

Nio Falls 4% as Memory Chip Costs and Revenue Miss Overshadow Doubled Vehicle Margin, XPeng Holds Steady

The Chinese electric vehicle sector is reacting a sharp cost-guidance warning, delivered inside what was arguably Nio's best profit quarter to date.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.